150 related articles for article (PubMed ID: 18194075)
1. Antigen-specific therapy of rheumatoid arthritis.
Ichim TE; Zheng X; Suzuki M; Kubo N; Zhang X; Min LR; Beduhn ME; Riordan NH; Inman RD; Min WP
Expert Opin Biol Ther; 2008 Feb; 8(2):191-9. PubMed ID: 18194075
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy in collagen-induced arthritis: past, present, and future.
Wooley PH
Am J Med Sci; 2004 Apr; 327(4):217-26. PubMed ID: 15084918
[TBL] [Abstract][Full Text] [Related]
3. Preclinical models of arthritis for studying immunotherapy and immune tolerance.
Meehan GR; Thomas R; Al Khabouri S; Wehr P; Hilkens CM; Wraith DC; Sieghart D; Bonelli M; Nagy G; Garside P; Tough DF; Lewis HD; Brewer JM
Ann Rheum Dis; 2021 Oct; 80(10):1268-1277. PubMed ID: 34380700
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis.
Thomas R
Arthritis Res Ther; 2013 Feb; 15(1):204. PubMed ID: 23374912
[TBL] [Abstract][Full Text] [Related]
5. Developing tolerogenic dendritic cell therapy for rheumatoid arthritis: what can we learn from mouse models?
Stoop JN; Robinson JH; Hilkens CM
Ann Rheum Dis; 2011 Sep; 70(9):1526-33. PubMed ID: 21804099
[TBL] [Abstract][Full Text] [Related]
6. Autoantigen-Dexamethasone Conjugate-Loaded Liposomes Halt Arthritis Development in Mice.
Benne N; Ter Braake D; Porenta D; Lau CYJ; Mastrobattista E; Broere F
Adv Healthc Mater; 2024 May; 13(12):e2304238. PubMed ID: 38295848
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells: the driving force behind autoimmunity in rheumatoid arthritis?
Pettit AR; Thomas R
Immunol Cell Biol; 1999 Oct; 77(5):420-7. PubMed ID: 10540208
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with endosomal unknown epitopes produces therapeutic response in rheumatoid arthritis patients and modulates adjuvant arthritis of rats.
Caruso I; Santandrea S; Gismondo M; Lombardi A; Montrone F; Caruso EM; Sarzi Puttini P
J Transl Med; 2016 Jun; 14(1):162. PubMed ID: 27268027
[TBL] [Abstract][Full Text] [Related]
9. Continuous nasal administration of antigen is critical to maintain tolerance in adoptively transferred autoimmune arthritis in SCID mice.
Bárdos T; Czipri M; Vermes C; Zhang J; Mikecz K; Glant TT
Clin Exp Immunol; 2002 Aug; 129(2):224-31. PubMed ID: 12165077
[TBL] [Abstract][Full Text] [Related]
10. Role of T-cells in the development of arthritis.
Gaston JS
Clin Sci (Lond); 1998 Jul; 95(1):19-31. PubMed ID: 9662482
[TBL] [Abstract][Full Text] [Related]
11. Oral tolerance in the control of experimental models of autoimmune disease.
Staines NA; Harper N
Z Rheumatol; 1995; 54(3):145-54. PubMed ID: 7660685
[TBL] [Abstract][Full Text] [Related]
12. Dissecting the contribution of innate and antigen-specific pathways to the breach of self-tolerance observed in a murine model of arthritis.
Nickdel MB; Conigliaro P; Valesini G; Hutchison S; Benson R; Bundick RV; Leishman AJ; McInnes IB; Brewer JM; Garside P
Ann Rheum Dis; 2009 Jun; 68(6):1059-66. PubMed ID: 18635595
[TBL] [Abstract][Full Text] [Related]
13. Experimental animal models for rheumatoid arthritis.
Choudhary N; Bhatt LK; Prabhavalkar KS
Immunopharmacol Immunotoxicol; 2018 Jun; 40(3):193-200. PubMed ID: 29433367
[TBL] [Abstract][Full Text] [Related]
14. Evidence that type II collagen feeding can induce a durable therapeutic response in some patients with rheumatoid arthritis.
Trentham DE
Ann N Y Acad Sci; 1996 Feb; 778():306-14. PubMed ID: 8610984
[No Abstract] [Full Text] [Related]
15. Collagen II-primed Foxp3 Transduced T Cells Ameliorate Collagen-induced Arthritis in Rats: The Effect of Antigenic Priming on T Regulatory Cell Function.
Zavvar M; Abdolmaleki M; Farajifard H; Noorbakhsh F; Azadmanesh K; Vojgani M; Nikcnam MH
Iran J Allergy Asthma Immunol; 2018 Aug; 17(4):361-371. PubMed ID: 30537799
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D Deficiency and Rheumatoid Arthritis.
Ishikawa LLW; Colavite PM; Fraga-Silva TFC; Mimura LAN; França TGD; Zorzella-Pezavento SFG; Chiuso-Minicucci F; Marcolino LD; Penitenti M; Ikoma MRV; Sartori A
Clin Rev Allergy Immunol; 2017 Jun; 52(3):373-388. PubMed ID: 27484684
[TBL] [Abstract][Full Text] [Related]
17. Antigen-specific tolerogenic and immunomodulatory strategies for the treatment of autoimmune arthritis.
Satpute SR; Durai M; Moudgil KD
Semin Arthritis Rheum; 2008 Dec; 38(3):195-207. PubMed ID: 18177689
[TBL] [Abstract][Full Text] [Related]
18. Treatment of autoimmune arthritis using RNA interference-modulated dendritic cells.
Zheng X; Suzuki M; Ichim TE; Zhang X; Sun H; Zhu F; Shunnar A; Garcia B; Inman RD; Min W
J Immunol; 2010 Jun; 184(11):6457-64. PubMed ID: 20435931
[TBL] [Abstract][Full Text] [Related]
19. Presence and role of anti-citrullinated protein antibodies in experimental arthritis models.
Cantaert T; Teitsma C; Tak PP; Baeten D
Arthritis Rheum; 2013 Apr; 65(4):939-48. PubMed ID: 23280233
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of autoimmunity in human diseases: a critical review of current dogma.
Benson RA; Brewer JM; Platt AM
Curr Opin Rheumatol; 2014 Mar; 26(2):197-203. PubMed ID: 24445477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]